Literature DB >> 16297841

Pathogenesis, clinical features, and neurological outcome of cerebral malaria.

Richard Idro1, Neil E Jenkins, Charles R J C Newton.   

Abstract

Cerebral malaria is the most severe neurological complication of Plasmodium falciparum malaria. Even though this type of malaria is most common in children living in sub-Saharan Africa, it should be considered in anybody with impaired consciousness that has recently travelled in a malaria-endemic area. Cerebral malaria has few specific features, but there are differences in clinical presentation between African children and non-immune adults. Subsequent neurological impairments are also most common and severe in children. Sequestration of infected erythrocytes within cerebral blood vessels seems to be an essential component of the pathogenesis. However, other factors such as convulsions, acidosis, or hypoglycaemia can impair consciousness. In this review, we describe the clinical features and epidemiology of cerebral malaria. We highlight recent insights provided by ex-vivo work on sequestration and examination of pathological specimens. We also summarise recent studies of persisting neurocognitive impairments in children who survive cerebral malaria and suggest areas for further research.

Entities:  

Mesh:

Year:  2005        PMID: 16297841     DOI: 10.1016/S1474-4422(05)70247-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  191 in total

1.  Perforin Expression by CD8 T Cells Is Sufficient To Cause Fatal Brain Edema during Experimental Cerebral Malaria.

Authors:  Matthew A Huggins; Holly L Johnson; Fang Jin; Aurelie N Songo; Lisa M Hanson; Stephanie J LaFrance; Noah S Butler; John T Harty; Aaron J Johnson
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

Review 2.  Hypoglycemia in critically ill children.

Authors:  E Vincent S Faustino; Eliotte L Hirshberg; Clifford W Bogue
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

3.  Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.

Authors:  Jin Guo; Armand W Guiguemde; Annael Bentura-Marciano; Julie Clark; Richard K Haynes; Wing-Chi Chan; Ho-Ning Wong; Nicholas H Hunt; R Kiplin Guy; Jacob Golenser
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

4.  Impairment of functional capillary density but not oxygen delivery in the hamster window chamber during severe experimental malaria.

Authors:  Judith Martini; Irene Gramaglia; Marcos Intaglietta; Henri C van der Heyde
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 5.  Diagnosis and management of the neurological complications of falciparum malaria.

Authors:  Saroj K Mishra; Charles R J C Newton
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

6.  Promoter polymorphisms in the ATP binding cassette transporter gene influence production of cell-derived microparticles and are highly associated with susceptibility to severe malaria in humans.

Authors:  Upasana Sahu; Biranchi N Mohapatra; Shantanu K Kar; Manoranjan Ranjit
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

7.  Inhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria.

Authors:  Marcele F Bastos; Ana Carolina A V Kayano; João Luiz Silva-Filho; João Conrado K Dos-Santos; Carla Judice; Yara C Blanco; Nathaniel Shryock; Michelle K Sercundes; Luana S Ortolan; Carolina Francelin; Juliana A Leite; Rafaella Oliveira; Rosa M Elias; Niels O S Câmara; Stefanie C P Lopes; Letusa Albrecht; Alessandro S Farias; Cristina P Vicente; Claudio C Werneck; Selma Giorgio; Liana Verinaud; Sabrina Epiphanio; Claudio R F Marinho; Pritesh Lalwani; Rogerio Amino; Julio Aliberti; Fabio T M Costa
Journal:  FASEB J       Date:  2018-03-20       Impact factor: 5.191

8.  Evaluation of Extracellular Vesicle Function During Malaria Infection.

Authors:  María Andrea Hernández-Castañeda; Smart Mbagwu; Kehinde Adebayo Babatunde; Michael Walch; Luis Filgueira; Pierre-Yves Mantel
Journal:  J Vis Exp       Date:  2018-02-14       Impact factor: 1.355

9.  The specific, reversible JNK inhibitor SP600125 improves survivability and attenuates neuronal cell death in experimental cerebral malaria (ECM).

Authors:  Sripada Santosh Anand; Mulaka Maruthi; Phanithi Prakash Babu
Journal:  Parasitol Res       Date:  2013-02-28       Impact factor: 2.289

10.  Long-term Behavioral Problems in Children With Severe Malaria.

Authors:  John Mbaziira Ssenkusu; James Steven Hodges; Robert Opika Opoka; Richard Idro; Elsa Shapiro; Chandy Chiramukhathu John; Paul Bangirana
Journal:  Pediatrics       Date:  2016-10-05       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.